MagnezixKids Study
"Magnesium-based, Bioresorbable Implants for Pediatric Elbow Fractures, a Single Center Pilot Study for Osteosynthesis With Magnezix Screws in Fractures of the Epicondylus Ulnaris and Condylus Radialis."
1 other identifier
interventional
17
1 country
1
Brief Summary
The overall objective of the study is to describe the outcomes of osteosyn-thesis with magnesium based screws in children with a primary or second-ary (within 7 days from trauma) dislocated fracture of the Epicondyles ul-naris or Condylus radialis, and to compare them with outcomes of conven-tional osteosynthesis using steel screws. If our results suggest non-inferiority of osteosynthesis with magnesium-based screws, the procedure could be tested formally in a subsequent full-size study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2020
CompletedFirst Submitted
Initial submission to the registry
August 11, 2020
CompletedFirst Posted
Study publicly available on registry
October 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 12, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 12, 2023
CompletedSeptember 6, 2023
September 1, 2023
2.9 years
August 11, 2020
September 5, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Clinical and radiologic outcome (fracture consolidation)
radiologic outcome after osteosynthesis with magnesium based screws in children with a primary or secondary (within 7 days from trauma) dislocated fracture of the Epicondyles ulnaris or Condylus radialis Fracture alignment is measured as dislocation distance (mm). Appropriate alignement is a postopera-tive dehiscence or dislocation of less than 5 mm in Epicondylus ulnaris fractures and less than 2 mm in Condylus radialis fractures, according to literature (26/27/31).
12 months
Secondary Outcomes (4)
Analgesic reuirement
12 months
ROM
12 months
Woundhealing
12 months
Clinical fracture consolidation after one year
12 months
Study Arms (1)
Syntellix Treatment Arm
OTHERGeneral anaesthesia, open fracture reduction, insertion of the appropriate screw with x-ray control and documentation intraoperatively, cast immobilisation Use of bioresorbable Magnezix CS or CBS Screws, if intraoperatively suitable bioresorbable screws not available, use of conventional ostesynthesis screws
Interventions
Osteosynthesis with Magnezix screws in fractures of the Epicondylus ulnaris and Condylus radialis under General anaesthesia
Eligibility Criteria
You may qualify if:
- primary or secondary (within 7 days from trauma) dislocated fracture of the Epicondyles ulnaris or Condylus radialis (indication for operative treatment according to international standard: Dislocation of more than 2 mm in Condylus radials fractures and more than 5 mm in Epicondylus ulnas fractures )
- Age 3-15 years
- Informed Consent as documented by signature
You may not qualify if:
- \- open fractures or complex multi fragment fractures that require dif-ferent osteosynthetic procedures than screw fixation
- severe local accompanying injury (injury to nerves/vessels)
- polytrauma patients
- fracture age \> 7 days
- preexisting ipsilateral elbow fracture
- relevant comorbidities, which have influence on fracture and wound healing
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant or the legal representatives
- Previous enrolment into the current study
- Enrolment of the investigator's family members and other dependent persons
- Any of the following applicable absolute and relative contraindica-tions listed in the MAGNEZIX® CBS and CSc 4.8 mm instruction for use :
- Absolute contraindications:
- insufficient or avascular bone mass for anchorage of the implant, ex-cept osteochondral fractures and dissecates
- confirmation or suspected septic infectious surgical site
- application in the area of the epiphyseal plates
- Relative contraindications:
- +6 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Thomas Krebslead
Study Sites (1)
Childres Hospital of Eastern Switzerland
Sankt Gallen, 9006, Switzerland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Surgeon in Chief, Member of the executive board
Study Record Dates
First Submitted
August 11, 2020
First Posted
October 1, 2020
Study Start
August 1, 2020
Primary Completion
July 12, 2023
Study Completion
July 12, 2023
Last Updated
September 6, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share